Drug-Delivery Panel Explores Emerging Platforms

From injection of drug agents into the suprachoroidal space surrounding the eye to a port for injection of anti-VEGF therapy, a number of companies in the retinal space are developing new methods for delivering drugs to the back of the eye. At OIS@ASRS 2017, incoming American Society of Retina Specialists president John Pollack, MD, moderates a panel on retinal drug delivery: with Szilard Kiss, MD, of Weill Cornell Medical College, David Boyer, MD, of Retina-Vitreous Associates Medical Group, and J. Michael Jumper MD, of West Coast Retina Medical Group.